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Toronto, Ontario, CanadaObjective: To study whether methylated CpG-island (CGI) ampliﬁcation coupled with microarray (MCAM) can be used to generate
DNA (deoxyribonucleic acid) methylation proﬁles from single human blastocysts.
Design: A pilot microarray study with methylated CpG-island ampliﬁcation applied to human blastocyst genomic DNA and hybridized
on CpG-island microarrays.
Setting: University research laboratory.
Patient(s): Five cryopreserved sibling 2-pronuclear zygotes that were surplus to requirements for clinical treatment by in vitro
fertilization were donated with informed consent from a patient attending Bourn Hall Clinic, Cambridge, United Kingdom.
Intervention(s): None.
Main Outcome Measure(s): Successful generation of genome-wide DNA methylation proﬁles at CpG islands from individual human
blastocysts, with common genomic regions of DNA methylation identiﬁed between embryos.
Result(s): Between 472 and 734 CpG islands were methylated in each blastocyst, with 121 CpG islands being commonly methylated in
all 5 blastocysts. A further 159 CGIs were commonly methylated in 4 of the 5 tested blastocysts. Methylation was observed at a number
of CGIs within imprinted-gene, differentially methylated regions (DMRs), including placental and preimplantation-speciﬁc DMRs.Use your smartphoneConclusion(s): The MCAM method is capable of providing comprehensive DNA methylation
data in individual human blastocysts. (Fertil Steril 2015;103:1566–71. 2015 by American
Society for Reproductive Medicine.)
Key Words: Preimplantation, CpG island, methylation, blastocyst, epigenetic
Discuss: You can discuss this article with its authors and with other ASRM members at http://
fertstertforum.com/huntrissj-cpg-island-ampliﬁcation-human-blastocysts/to scan this QR code
and connect to the
discussion forum for
this article now.*
* Download a free QR code scanner by searching for “QR
scanner” in your smartphone’s app store or app marketplace.pigenetic programming, which isReceived May 10, 2013; revised March 19, 2015; accepted March 20, 2015; published online April 22,
2015.
J.H. has received grants from Newlife Foundation (BDF Newlife Ref 06/26) and fromMedical Research
Council (grant No. G0701388). K.H. has nothing to disclose. P.B. has nothing to disclose. L.H. has
nothing to disclose. K.E. has nothing to disclose. C.V. has nothing to disclose. D.M. has nothing to
disclose. H.M.P. has received grants from Medical Research Council, United Kingdom, from Fer-
ring Pharmaceuticals, and from the Society for Reproduction and Fertility; and is a paid consul-
tant for Origio (Denmark).
Reprint requests: John Huntriss, Ph.D., Division of Reproduction and Early Development, Leeds Insti-
tute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire,
United Kingdom LS2 9JT (E-mail: j.huntriss@leeds.ac.uk).
Fertility and Sterility® Vol. 103, No. 6, June 2015 0015-0282
Copyright ©2015 The Authors. Published by Elsevier Inc. on behalf of the American Society for Repro-
ductive Medicine. This is an open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).
http://dx.doi.org/10.1016/j.fertnstert.2015.03.020
1566E essential for normal develop-ment, is highly regulated during
mammalian gametogenesis and preim-
plantation development (1) and includes
the modiﬁcation of a range of DNA
(deoxyribonucleic acid) sequence ele-
ments by DNA methylation (2, 3). The
epigenetic programming of human
gametes and preimplantation embryos
that develop in vitro may be affected
by assisted reproductive technology
(ART) (4). Moreover, ART seems to
induce subtle epigenetic effects thatVOL. 103 NO. 6 / JUNE 2015
Fertility and Sterility®may lead to greater risk of diseases in adult life (5–9). In human
ART, it is imperative to provide a regimen that supports
epigenetic programming that is compatible, as far as
possible, with normal development of the conceptus.
Deﬁning the DNA methylome of the human preimplantation
embryo may reveal which genomic regions may be
susceptible to the effects of embryonic development in vitro,
by identifying their requirement for a speciﬁc methylation
state in early development.
In this pilot study, we sought to identify whether genome-
wide DNA methylation analysis of CpG (C–phosphate–G)
islands is feasible in single human blastocysts. These islands
(CGIs) are regions of the genome important in regulating
gene expression in a manner dictated by their methylation
status (10, 11). Methylated CGI ampliﬁcation coupled with
microarray (MCAM) (12) is a method of DNA methylation
analysis that has been used to assess CGI methylation in
several human disease states (13–15).
MATERIALS AND METHODS
Samples
In the current report, a cohort of 5 cryopreserved sibling
in vitro fertilization (IVF), 2-pronuclear zygotes (surplus to re-
quirements for clinical treatment) were donated, with
informed consent, from a couple attending Bourn Hall Clinic
(Cambridge, United Kingdom) (maternal age: 29 years). Em-
bryos were obtained under protocols approved by the local
research ethics committees, which were licensed by the
Human Fertilisation and Embryology Authority. Zygotes
were thawed, equilibrated, and cultured individually to the
blastocyst stage under embryo-tested mineral oil at 37C
under 5% CO2 in humidiﬁed air.
Embryos numbered 1, 3, and 5were cultured in 4-ml drop-
lets of a deﬁned embryo culture medium based on the compo-
sition of human tubal ﬂuid that was comprised of Earle's
balanced salt solution, supplemented with 1 mmol/L of
glucose, 5 mmol/L of lactate, 0.47 mmol/L of pyruvate,
0.5% (vol/vol) human serum albumin (Zenalb 20, Bio Prod-
ucts Laboratory), and amino acids at close-to-physiologic
concentrations, essentially as previously described (16–18).
Embryos numbered 2 and 4 were initially cultured in 4-ml
droplets of EmbryoAssist before transfer to equivalent-sized
microdrops of BlastAssist medium (both from Origio).
Morphologic grading was recorded as described previously
(18). The blastocysts used in the study are shown in
Supplemental Figure 1 (available online).
At the end of culture, blastocysts were allowed to perish.
They were washed in Ca2þ andMg2þ-free phosphate buffered
saline (Life Technologies, Ltd) at 4C. Zona pellucidae were
removed by brief exposure to acid Tyrode's solution (Sigma),
and each individual blastocyst was snap-frozen in lysis buffer
(Dynal, Life Technologies, Ltd). Genomic DNA was isolated
from blastocysts using the Qiagen DNA Micro kit (Qiagen).
Methylated CpG-Island Ampliﬁcation Coupled
with CpG-Island Microarray
Methylated CGI ampliﬁcation was performed according to
earlier reports (12, 15), with minor modiﬁcations. Brieﬂy,VOL. 103 NO. 6 / JUNE 2015embryonic DNA was digested for 16 hours in total, with 2
consecutive digestions of 8 hours, each using 8 units of
methylation-sensitive SmaI restriction enzyme (New England
Biolabs) at 25C, followed by heat inactivation (95C, for 10
minutes). Subsequently, DNA was digested with 15 units of
XmaI for 6 hours, at 37C, followed by heat inactivation.
The residual methylated DNA fragments were precipi-
tated with alcohol and ligated to 0.5 nmol of RXMA polymer-
ase chain reaction (PCR) adaptors (12), using T4 DNA ligase
(New England Biolabs) in a 10-ml reaction volume. The
RXMA PCR adaptors were prepared by combining the 2
oligonucleotides RXMA24 (5-AGCACTCTCCAGCCTCTCAC
CGAC-3) and RXMA12 (5-CCGGGTCGGTGA-3) at 65C for
5 minutes, and annealed by cooling.
Methylated DNA was ampliﬁed by PCR using the entire
ligation reaction in a 50-mL volume containing 100 pmol of
RXMA24 oligonucleotide, and 5 units of Advantage 2 Taq
DNA polymerase (Clontech). Before ampliﬁcation, the PCR re-
action mixture was incubated at 72C for 5 minutes, and 95C
for 3 minutes. The DNAs were subjected to 35 cycles of 1 min-
ute at 95C, and 3 minutes at 72C, with a ﬁnal extension step
(72C) of 10 minutes.
A 5-ml aliquot of each PCRproductwas assessed on a 1.2%
(w/v) agarose gel, with ethidium bromide staining, with a
smear from 300 bp to 3 Kb indicating successful ampliﬁcation
of methylated DNA. TheMCAMPCR products from each blas-
tocyst were puriﬁed using the PCR puriﬁcation kit (Qiagen),
and labelled and hybridized individually to Agilent 244K Hu-
man CpG island arrays that feature 27,800 CGIs, at the Ontario
Cancer Institute Genomics Centre. Bioinformatic processing
and subsequent bioinformatic analysis was performed, as
detailed in the Supplemental Bioinformatic Methods (avail-
able online). Blastocyst methylation data were compared
against methylation data obtained from the ENCODE project
for cell lines includingGM12878, HI-hESC (human embryonic
stem cell), HeLa-S3, HUVEC, K562, HMEC, and HepG2 (see
Supplemental Bioinformatic Methods).RESULTS
Methylated CGI ampliﬁcation was successful for each of the 5
blastocysts. After hybridization of these products individually
to Agilent 244K Human CpG island arrays, data analysis iden-
tiﬁed2,903methylatedCGIs in total, across all 5 blastocysts (see
Supplemental Bioinformatic Methods for further details). Of
these, 1,263CGIsweremethylated inR1 blastocyst (data avail-
able upon request). Thus, for embryos 1–5, respectively, the
number of methylated CGIs was 472, 569, 565, 734, and 563.
We hypothesized that the most stringent data would be
represented by CGIs that were methylated in all 5 blastocysts,
and observed 121 CGIs that met this criterion (24 CGIs were
expected by chance; see Supplemental Table 1, available on-
line). The distribution of the methylated CGIs across the
genome is shown in Figure 1, with CGIs that were methylated
in all 5 blastocysts listed in Supplemental Table 2 (available
online). Speciﬁc examples of CGIs methylated in all 5 blasto-
cysts are shown in Figure 2A–2H.
The methylated CGIs detected by MCAM included those
that were located toward the subtelomeric regions, consistent1567
FIGURE 1
Distribution of CpG islands that are methylated in blastocysts across the human genome, as generated by MCAM. Red bars represent CGIs
methylated in all 5 embryos; green bars represent CGIs methylated in 4 of 5 embryos. CGI ¼ CpG island; CpG ¼ C phosphate G; MCAM ¼
methylated CpG island ampliﬁcation coupled with microarray.
Huntriss. CpG-island methylation in human blastocysts. Fertil Steril 2015.
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pomethylation in mouse preimplantation embryos (19), and
subtelomeric hypermethylation in human induced pluripotent
cells (20). We observed 159 CGIs that were methylated in 4 of
the 5 tested blastocysts (see Fig. 2I–2O; and Supplemental
Table 3, available online). The NOTCH1 gene had 2 CGIs that
were methylated in 3 of the 5 embryos, and several additional
CGIs that exhibited variable methylation between embryos
(Fig. 2P). The distribution ofmethylated CGIs,within gene pro-
moters, enhancers, and intragenic regions, are shown in
Supplemental Figure 2 (available online) and reveals a pre-
dominance of CGI methylation in the gene body.
Gene ontology analysis was undertaken to investigate
whether the methylated loci possess a common ontology
term, and identiﬁed chromatin remodelling complex, nega-
tive regulation of transcription, transcriptional repressor
complex, and negative regulation of the RNA (ribonucleic
acid) metabolic process as the signiﬁcantly over-represented
terms (Supplemental Table 4, available online). Functional
annotations of the genes with methylated CGIs in all blasto-
cysts identiﬁed annotations including proto-oncogene,
glioma, small cell lung cancer, and extracellular matrix–re-
ceptor interaction categories (Supplemental Table 5, available
online). Principal component analysis and hierarchic clus-
tering were performed using the 1,263 positions that were
methylated in R1 sample (see Supplemental Figs. 3 and 4,
available online). Both of these methods show that sample 4
was the most divergent, relative to the other 4 samples.
Methylation of DNA was observed in blastocysts at CGIs
that were located within or proximal to 27 transcripts that are
known or predicted to be imprinted (Supplemental Table 6,
available online), although not all of these CGIs were methyl-
ated in every blastocyst. Methylation was observed in at least
15 known imprinted gene differentially methylated regions1568(DMRs), including several that are speciﬁc to the placenta
and/or preimplantation embryos.DISCUSSION
In this study, we established that theMCAMmethod is suitable
for CGI methylation analysis in individual human blastocysts.
We observed 121 CGIs that were methylated in all tested em-
bryos, indicating that these regions may represent an epige-
netic pattern common to this stage of human development.
Methylation was observed at 27 known or predicted im-
printed genes, including at least 15 known imprinted gene
DMRs (Supplemental Table 6). A conclusive determination
of whether the methylated DMRs identiﬁed by MCAM repre-
sented methylation imprints was not possible, because
methylation imprints are expected to be in the region of
35% to 65% methylation (21). The MCAM protocol as applied
in this study would be likely to identify only the DMRs with
the higher levels within that range. We suggest, therefore,
that quantitative approaches, such as pyrosequencing
methylation analysis, be applied in future experiments, to
precisely determine the methylation status of these regions.
An additional consideration is that some of the methyl-
ation observed at imprinted genes may not be relevant to
the process of imprinting—for example, in areas where
methylation occurs outside of known DMRs. Among the
CGIs methylated in all 5 blastocysts was CpG island 85, which
corresponds to the DMR of the imprinted transcript of the RB1
gene (Fig. 2H), a DMR that we previously demonstrated, using
pyrosequencing, to be methylated in human blastocysts (22).
In addition, methylation was observed at known DMRs for the
imprinted GNAS locus transcripts on chromosome 20.
Methylation was observed in 5 known placental and/or
preimplantation-speciﬁc DMRs (Supplemental Table 6) thatVOL. 103 NO. 6 / JUNE 2015
FIGURE 2
(A–H) Examples of loci with CpG islands that are methylated in all embryos (5 of 5), as obtained from the University of California, Santa Cruz
browser. Black horizontal bars represent methylation coverage across a deﬁned CGI (green) for each embryo. Overlapping loci (RefSeq genes)
are blue. (I–L) Examples of loci with CpG islands that are methylated in 4 of the 5 tested embryos. (M–P) Examples of loci with multiple
contiguous methylated CpG islands in most embryos. For these panels, the corresponding methylation data, as obtained from the ENCODE
data for the human cells lines GM12878, HI-hESC (human embryonic stem cell), K562, HeLa-S3, and HepG2 are shown.
Huntriss. CpG-island methylation in human blastocysts. Fertil Steril 2015.
Fertility and Sterility®are associated with the imprinted transcripts GLIS3, AIFM2,
FAM196A/DOCK1, DNMT1 (see Fig. 2L), and RHOBTB3.
However, not all the embryos were methylated at these re-
gions. Therefore, one possibility is that some placental-
speciﬁc methylation imprints initially become detectable in
the human blastocyst, possibly in the trophectoderm,
although further experimentation is required to clarify this.
We suggest that CpG 121 within the neurotrimin gene
(NTM) may represent a placental-speciﬁc DMR that is also
detectable in late preimplantation development; therefore,
further investigation is required for conﬁrmation.
For some loci, multiple contiguous CGIs were shown to be
methylated in each embryo, although methylation varied,
both in extent and speciﬁc CGI marking across such regions
between embryos (for example, ASPSCR1, PLXNB2,
PPP2R3B, ZFR2, and NOTCH1; see Fig. 1M–1P). TheVOL. 103 NO. 6 / JUNE 2015observed differences in DNA methylation between embryos
may be due to interembryo variability in developmental
competence, growth, and metabolism, although further
research is required to explore these possible inﬂuences. We
found that 88 of the 121 blastocyst-methylated CGIs were
additionally methylated in other cell lines as deﬁned by the
ENCODE project. This ﬁnding suggests that the remaining
sites may include some blastocyst-speciﬁc methylated sites,
(indicated as ‘‘not conﬁrmed’’ in Supplemental Table 2). Given
that these CGIs were not methylated in the HI-hESC human
embryonic stem cell line, some of the methylated CGIs that
were identiﬁed in blastocysts may include trophectoderm-
speciﬁc methylation sites; however, further experiments are
required to conﬁrm this possibility.
In some cases,R2 CpG islands within a particular locus
were observed to be methylated. The genes KIF26A, GAS6,1569
ORIGINAL ARTICLE: GENETICSCACNA1H, TAOK2, CTDP1, and BSG were observed to have
2 methylated CGIs in all 5 blastocysts, and all 5 embryos ex-
hibited 3 methylated CGIs at ASPSCR1. The genes SLC9A3,
SLC12A7, MAD1L1, IQCE, PTPRN2, CACNA1B, LRP5,
PPP2R3B, and PLEC were all observed to have 2 methylated
CGIs in 4 of 5 blastocysts.
The number of highly methylated CGIs in human blasto-
cysts is likely to be low relative to gametes and other tissues,
owing to the prior genome-wide erasure of methylation dur-
ing earlier preimplantation development, as conﬁrmed by the
low methylation levels reported in mouse blastocysts (23, 24).
However, some of the methylated CGIs detected in our study
may have survived erasure during preimplantation
development or may be the product of the initial stages of
de novo methylation, corresponding well with the
expression of DNA methyltransferases in human blastocysts
(25, 26).
We acknowledge that our pilot MCAM study is limited in
that only 5 individual blastocysts were analyzed. These
single-embryo hybridizations to CpG island arrays have iden-
tiﬁed only the most highly methylated CGIs that were consis-
tent across the tested embryos. Cohybridization experiments
(2-color) against other suitable cell types are highly likely to
reveal additional developmental stage–speciﬁc methylation
data, and regions of hypomethylation in human blastocysts.
Unfortunately, further embryonic DNA was not available to
perform these experiments.
In addition, we acknowledge that quantitative, higher-
resolution methods of DNA methylation analysis, such as
reduced representation bisulphite sequencing, have been
used very successfully for DNA methylation proﬁling in
mouse oocytes and preimplantation embryos (23, 24, 27),
but these earlier studies required the pooling of large
numbers of embryos, a strategy that cannot be applied for
the study of human preimplantation embryos. More
recently, however, the sensitivity of this type of sequencing
has been improved, to allow comprehensive DNA
methylation analysis in pooled samples containing small
numbers of embryos (28–30).
The MCAM analysis reported here permitted the analysis
of individual embryos to reveal that although methylation
patterns among embryos vary considerably, a common set
of CGIs are methylated in all (5 of 5) or most (4 of 5) embryos.
Such ﬁndings would be masked by pooling samples before
analysis. Therefore, MCAM may be useful as a method for
methylation proﬁling of CpG islands in individual or small
numbers of pooled preimplantation embryos. A number of
cancer-related genes (e.g., RB1, ST5, MTA1, CXXC5, GAS6,
SMARCA4, JAK2, WNK2, and HDAC4) were shown in this
study to have methylated CGIs.
This pilot study did not attempt to evaluate the impact of
various culture media conditions on CGI methylation in hu-
man blastocysts, because the numbers of sibling embryos
available for analysis within this cohort were far too few to
support such a challenging agenda. However, the 121
commonlymethylated CGIs were conserved between embryos
cultured in 2 different culture systems, regardless of whether a
single medium (EBSS with deﬁned supplements) or a sequen-
tial system (EmbryoAssist followed by BlastAssist) was used.1570Further, when principal component analysis and hierar-
chic clustering were performed using the 1,263 CGIs that
were methylated in R1 of the blastocyst samples
(Supplemental Figs. 3 and 4), both methods of analysis indi-
cated that similar methylation patterns were observed, espe-
cially between blastocysts 2 and 5, suggesting consistency
between blastocysts derived after culturing in 2 different me-
dia systems. However, the same methods indicated that
methylation of blastocyst 4 (cultured in EmbryoAssist fol-
lowed by BlastAssist) was distinct from the other 4 blastocysts
analyzed. The methylation differences observed for this
particular embryo may, however, involve several factors
that cannot be elucidated in the present study.
A method similar to MCAM has been used to assess DNA
methylation on chromosome 7 in single mouse blastocysts
(31). Use of this method supports our conclusions that
methods that employ methylation-sensitive enzyme diges-
tion, when coupled with microarrays, provide a viable
approach for genome-wide DNA methylation analysis when
single-embryo analysis is required.
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SUPPLEMENTAL FIGURE 1
Images of the human preimplantation embryos used in the MCAM study, indicating the number of methylated CGIs in each embryo. CGI ¼ CpG
island; MCAM ¼ methylated CpG island ampliﬁcation coupled with microarray.
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SUPPLEMENTAL FIGURE 2
Analysis of the CGIs that were methylated inR4 embryos, to identify
whether the methylated embryonic CGIs overlap with gene
promoters, enhancers, or intragenic regions. The analysis of
promoter, enhancer, and intragenic overlaps were performed
independently; therefore, in some cases, the same CGI might
overlap enhancer/promoter and intragenic regions, and therefore
may have been counted more than once. CGI ¼ CpG island.
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SUPPLEMENTAL FIGURE 3
Principal component analysis and hierarchical clustering show that
sample 4 was the most divergent, relative to the other 4 samples.
PC ¼ principal component.
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SUPPLEMENTAL FIGURE 4
Cluster dendrogram of methylation pattern with bootstrap
resampling.
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